Status | Study |
COMPLETED |
Study Name: Effect of Tigulixostat on the Pharmacokinetics of Theophylline Condition: Gout Date: 2023-12-07 Interventions: 300 mg oral dose |
RECRUITING |
Study Name: Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia Condition: Gout Date: 2023-09-07 Interventions: dotinurad alone |
RECRUITING |
Study Name: Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout Condition: Gout Date: 2023-04-05 Interventions: Low, medium or high dose (Part 1); Selected dose(s) (Part 2) |
RECRUITING |
Study Name: Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout Condition: Gout Date: 2022-12-19 Interventions: increasing dose of D-0120 |
RECRUITING |
Study Name: Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients Condition: Gout Date: 2022-10-16 Interventions: Xanthine Oxidase Inhibitor |
RECRUITING |
Study Name: Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical Trial Condition: Gout Date: 2019-12-12 Interventions: Patients will be randomly assigned to the routine treatment + placebo group and probiotics + routine treatment group according to 1:2 ratio. |
Recruiting |
Study Name: Novel Methods for Ascertainment of Gout Flares -A Pilot Study Condition: Gout Date: 2016-07-28 Interventions: Device: IVR (Phone call) IVR w |
Active, not recruiting |
Study Name: Virtual Gout Clinic Condition: Gout Date: 2016-05-31 Interventions: Behavioral: Pharmacist-Led Intervention Pharmacists will conduct outreach primarily via an automated tel |
Terminated |
Study Name: Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects. Condition: Gout Date: 2014-07-08 Interventions: Drug: PF-06743649 Daily dosing |
Completed |
Study Name: Safety and Efficacy of Oral Febuxostat in Subjects With Gout Condition: Gout Date: 2014-03-06 Interventions: Drug: Febuxostat Drug: Allopurinol |